Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Most low-level light therapy studies did not accurately report how light was measured, affecting treatment reliability.

Researchers developed a model that shows hair follicles increase skin absorption of caffeine by 20%.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Ethosomal carriers effectively deliver hair loss drug into skin.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Heat and chemicals improve finasteride delivery to scalp and hair follicles, potentially enhancing treatment for hair loss.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Hair loss and excessive growth treated with various options, including new laser technology.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Nanoencapsulated antibiotics are more effective in treating hair follicle infections than free antibiotics.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.